Copper therapy shows cognitive improvement in Alzheimer’s disease patients

Copper may slow cognitive decline in early Alzheimer's disease, but evidence remains mixed and risks require careful monitoring.

Copper may slow cognitive decline in early Alzheimer's disease, but evidence remains mixed and risks require careful monitoring.

Mediterranean foods supply polyphenols and omega-3s that reduce brain inflammation and support memory—no supplements needed.

A new USC-led study reveals dementia care will consume $818 billion in 2026, with most costs borne by patients, families, and lost productivity rather than medical expenses.

Annual dementia care costs have surged to $818 billion, with 80% of the burden falling directly on families.

Live and curated music performances offer dementia residents neurological pathways to engagement that differ from standard care routines, often reducing agitation and medication needs.

Dogs with cognitive dysfunction show predictable warning signs—disorientation, lost house training, and withdrawn behavior—often months before diagnosis.

A specialized $20 million memory care facility opening in Fayetteville next summer will serve 68 residents with Alzheimer's disease and dementia, featuring secure courtyards and round-the-clock care.

Neurological exams for dementia test memory, movement, and reflexes to help doctors pinpoint whether cognitive changes point to Alzheimer's, stroke, or a treatable condition.

The MoCA test screens for cognitive decline in 10 minutes using a 30-point scale; a score of 26 or above typically means normal cognition, while below 26 suggests closer evaluation.

Doctors test memory, language, attention, and executive function with specific cognitive tools to distinguish dementia from normal aging.